Pharmaceutical composition for treating various serious diseases and preparation and use thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A drug and technology for serious diseases, applied in the field of drug combination and its preparation and application for the treatment of various serious diseases, can solve problems such as loss of labor and self-care ability, burden, poor life status of patients, etc.
Pending Publication Date: 2014-05-28
蔡欣
View PDF5 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Cardiovascular and cerebrovascular diseases, diabetes and its complications, high blood pressure, hyperlipidemia and many other serious illness patients not only lose their labor force and self-care ability, but also require several family members to take care of them when they are hospitalized. big burden
The current treatment methods for cancer patients are surgery, chemotherapy, and radiotherapy. The patient's own life condition is poor, and the prognosis of this toss is very poor.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0030] Example 1, compound fermented Cordyceps powder / aspirin oral preparation raw material weight ratio:
[0031] Fermented Cordyceps powder or pure Cordyceps 0.25
[0032] Aspirin, or aspirin lysine, or aspirin arginine 0.20
[0033] Reduced glutathione, as an antioxidant 0.01
[0034] The preparation steps and method of the compound fermented Cordyceps powder / aspirin oral preparation are the same as above.
example 2
[0035] Example 2, compound fermented Cordyceps powder / aspirin oral preparation raw material weight ratio:
[0036] Fermented Cordyceps powder or pure Cordyceps 0.75
[0037] Aspirin, or aspirin lysine, or aspirin arginine 0.9
[0038]Reduced glutathione, as an antioxidant 0.15
[0039] The preparation steps and method of the compound fermented Cordyceps powder / aspirin oral preparation are the same as above.
example 3
[0040] Example 3, compound fermented Cordyceps powder / aspirin oral preparation raw material weight ratio:
[0041] Fermented Cordyceps powder or pure Cordyceps 0.25
[0042] Aspirin, or aspirin lysine, or aspirin arginine 0.9
[0043] Reduced glutathione, as an antioxidant 0.01
[0044] The preparation steps and method of the compound fermented Cordyceps powder / aspirin oral preparation are the same as above.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
weight
aaaaa
aaaaa
weight
aaaaa
aaaaa
Login to view more
Abstract
The invention relates to a pharmaceutical composition for treating various serious diseases. The pharmaceutical composition is characterized by comprising the following raw materials with effective components in weight ratio: 0.25-0.75 of fermented cordyceps taishanensis powder or pure cordyceps sinensis, 0.20-0.90-0 of aspirin, or aspirin-DL-lysine, or aspirin-arginine, 0.00005-0.00025 of alprostadil, 0.35-0.85 of taurine, 0.010-0.02 of 2-hydroxypropyl-cyclodextrin, 0.00010-0.00030 of sodium hydrogen sulfite, 500-600 of xylitol and 130 / 0.4400-500 of hydroxyethyl starch. The invention further provides preparation steps and method. The pharmaceutical composition is used for resisting aging, fatigue, oxygen deficit and optical radiation, improving the immunity, resisting myocardial ischemia and cerebral ischemia, treating diabetes and complications thereof, reducing blood pressure and blood fat, and resisting tumors.
Description
technical field [0001] The invention relates to a drug combination, preparation and use, which are used for treating various serious diseases such as cardiovascular and cerebrovascular diseases, diabetes and its complications, hypertension, and hyperlipidemia, and for treating tumors in parts of the body. Background technique [0002] Cardiovascular and cerebrovascular diseases, diabetes and its complications, high blood pressure, hyperlipidemia and many other serious illness patients not only lose their labor force and ability to take care of themselves, but also require several family members to take care of them when they are hospitalized. Big burden. The current treatment methods for cancer patients are surgery, chemotherapy, and radiotherapy. The patient's own life condition is poor, and the prognosis of this toss is very poor. Contents of the invention [0003] This invention has gone through 20 years of combined research on pharmacy and treatment. On the basis of t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more